BIO-Europe Spring® 2016: What alliance opportunities excite Genentech?

May 12, 2016

Dr. Thomas Zioncheck, senior director of Genentech Partnering (a unit of Roche subsidiary Genentech Inc.), speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, during the BIO-Europe Spring® partnering conference in Stockholm, Sweden, about what alliances the company is seeking and how it beats off the competition for highly sought-after assets. Zioncheck explains what startups and biotechs need to bring to the table and why they need to bring those packages to Genentech. He also talks about Genentech's global search for new assets and its key therapy areas of interest.

 


Want to elevate your brand and connect with potential partners? The Cell & Gene Exchange brings together leaders from patient advocacy groups, industry, academia and government to network, exchange ideas and explore partnership opportunities. Learn more here. 

Previous Video
BIO-Europe Spring® 2016: PILA Pharma CEO explains potential of "chili receptor" as diabetes therapy
BIO-Europe Spring® 2016: PILA Pharma CEO explains potential of "chili receptor" as diabetes therapy

Dr. Dorte Gram, CEO of PILA Pharma AB, one of Sweden's youngest biotech companies, talks to Mike Ward, glob...

Next Video
BIO-Europe Spring® 2016: Sprint Bioscience on preclinical focus and plans for long-term independence
BIO-Europe Spring® 2016: Sprint Bioscience on preclinical focus and plans for long-term independence

Anne-Marie Wenthzel, VP of business development at Sprint Bioscience, chats with Sten Stovall during the BI...